디지털 바이오 제조 시장 규모, 점유율, 성장 및 세계 업계 분석, 지역별 동향 및 예측(2026-2034년)

Growth Factors of digital biomanufacturing Market

The global digital biomanufacturing market was valued at USD 22.44 billion in 2025 and is projected to grow to USD 25.16 billion in 2026. The market is expected to reach USD 66.14 billion by 2034, expanding at a CAGR of 12.84% during the forecast period. The increasing production of biologics, biosimilars, vaccines, cell therapies, and gene therapies, coupled with rising demand for automation and digital process optimization, is driving market expansion. In 2025, North America dominated the digital biomanufacturing market, accounting for 41.27% of the global market share.

Digital biomanufacturing combines automation, connected equipment, process analytics, manufacturing execution systems (MES), electronic batch records (eBR), artificial intelligence, and real-time monitoring to optimize biologics manufacturing. The growing adoption of single-use technologies, increasing outsourcing to contract development and manufacturing organizations (CDMOs), and the transition from paper-based documentation to connected digital workflows continue to accelerate market growth worldwide.

Market Trends

A major trend in the digital biomanufacturing market is the growing adoption of automation and real-time process control. Biopharmaceutical manufacturers are replacing manual production methods with integrated digital platforms capable of monitoring critical process parameters such as pH, dissolved oxygen, temperature, pressure, and feed rates in real time.

The integration of SCADA systems, distributed control systems (DCS), process analytical technology (PAT), cloud platforms, and AI-driven monitoring tools is improving manufacturing consistency, reducing batch failures, and accelerating technology transfer across development and commercial production facilities.

Market Drivers

The rapid expansion of biologics, biosimilars, vaccines, recombinant proteins, cell therapies, and gene therapies remains the primary growth driver for the digital biomanufacturing market. Unlike conventional pharmaceutical manufacturing, biologics production requires highly controlled, data-intensive manufacturing environments with strict regulatory compliance.

Digital manufacturing platforms help reduce manual errors, improve batch consistency, simplify regulatory documentation, accelerate process scale-up, and enhance technology transfer across multiple manufacturing sites. Increasing investments by CDMOs and biopharmaceutical companies in advanced manufacturing facilities continue supporting strong market growth.

Market Restraints

High implementation costs remain a major challenge for digital biomanufacturing adoption. Deploying integrated digital manufacturing systems requires significant investments in automation infrastructure, MES, electronic batch records, process analytical technologies, cybersecurity, data integration, validation, employee training, and ongoing technical support.

Smaller biotechnology companies and regional manufacturers often adopt digital technologies gradually because of budget limitations and the complexity of integrating modern platforms with existing legacy systems.

Market Opportunities

Growing regulatory support for advanced pharmaceutical manufacturing presents significant growth opportunities for the industry. Regulatory agencies increasingly encourage the adoption of automation, digital twins, robotics, AI, and real-time monitoring technologies that improve manufacturing consistency and product quality.

The increasing commercialization of advanced therapies, including cell and gene therapies, is creating strong demand for digitally connected manufacturing platforms capable of delivering scalable, validated, and regulatory-compliant production environments.

Market Challenges

A shortage of skilled professionals with expertise in both bioprocess engineering and digital manufacturing technologies remains one of the industry's key challenges. Successful implementation requires specialists experienced in automation, artificial intelligence, MES, process analytical technology, data integration, validation, cybersecurity, and quality management.

The limited availability of qualified personnel increases implementation costs, delays deployment schedules, and slows the realization of productivity improvements following digital investments.

Segmentation Analysis

Based on offering, the hardware and connected equipment segment dominated the market in 2025 due to substantial investments in automated bioreactors, connected single-use systems, and integrated manufacturing equipment. Meanwhile, the services segment is expected to witness the fastest growth as companies increasingly require consulting, validation, system integration, and technical support.

By type, the automation and process control segment holds the largest market share because biologics manufacturing depends heavily on continuous monitoring and control of critical production parameters. The AI, machine learning, and advanced analytics segment is projected to record the highest growth throughout the forecast period.

According to application, commercial GMP manufacturing execution remains the dominant segment as manufacturers increasingly adopt paperless batch records, automated production workflows, and regulatory-compliant manufacturing systems. Technology transfer and facility digitalization are also expanding rapidly as companies modernize production facilities.

By end user, pharmaceutical and biotechnology companies account for the largest market share due to significant investments in biologics manufacturing capacity, digital transformation, and global production expansion. Contract manufacturing organizations (CMOs) and CDMOs are also experiencing strong demand as outsourcing continues to grow.

Regional Outlook

North America led the global digital biomanufacturing market in 2025, generating USD 9.26 billion in revenue. The region benefits from extensive biologics manufacturing capacity, advanced automation technologies, strong regulatory support, and widespread adoption of digital manufacturing platforms. The U.S. market is projected to reach USD 9.42 billion in 2026, representing approximately 37.5% of global revenue.

Europe remains the second-largest market, supported by established biologics manufacturing infrastructure, increasing adoption of digital manufacturing systems, and favorable regulatory policies.

Asia Pacific is expected to experience the fastest growth, reaching USD 5.70 billion in 2026. Rapid expansion of biologics manufacturing, CDMO capacity, vaccines, biosimilars, and advanced therapies across China, India, Japan, South Korea, Singapore, and Australia continues driving regional demand.

Meanwhile, Latin America and the Middle East & Africa are witnessing steady market expansion through increasing investments in pharmaceutical manufacturing, healthcare infrastructure, and local biologics production.

Competitive Landscape

The digital biomanufacturing market remains moderately fragmented, with major companies focusing on integrated automation platforms, cloud-based manufacturing systems, AI-driven analytics, digital twins, and connected laboratory informatics. Leading industry participants include Siemens, Sartorius AG, Danaher Corporation (Cytiva), Emerson Electric Co., Korber AG, Aspen Technology, Benchling, TetraScience, Schneider Electric, and Rockwell Automation. Strategic partnerships, portfolio expansion, and technological innovation continue to strengthen competitive positioning across the global market.

Conclusion

The global digital biomanufacturing market is expected to grow significantly from USD 22.44 billion in 2025 to USD 25.16 billion in 2026, reaching USD 66.14 billion by 2034. Increasing production of biologics, biosimilars, vaccines, and advanced therapies, together with rising adoption of automation, artificial intelligence, and connected manufacturing systems, will continue driving market growth. Although implementation costs and workforce shortages remain key challenges, ongoing technological advancements, regulatory support, and expanding digital transformation across biopharmaceutical manufacturing are expected to create substantial long-term growth opportunities throughout the forecast period.

Segmentation By Offering, Type, Application, End User, and Region

By Offering * Software & Platforms

• Hardware & Connected Equipment
• Services

By Type * Manufacturing Execution & Electronic Batch Records

• Automation & Process Control
• Process Analytical Technology & Real-time Monitoring
• Digital Twins, Modeling & Simulation
• AI, Machine Learning & Advanced Analytics
• Bioprocess Data Management & Integration
• Quality & Laboratory Informatics
• Others

By Application * Process Development & Scale-up

• Commercial GMP Manufacturing Execution
• Real-time Process Monitoring & Control
• Quality Management & Batch Release
• Technology Transfer & Facility Digitalization
• Others

By End User * Pharmaceuticals & Biotechnology Companies

• Academic & Research Institutes
• CMOs & CDMOs
• Others

By Region * North America (By Offering, Type, Application, End User, and Country)

• U.S.
• Canada
• Europe (By Offering, Type, Application, End User, and Country/Sub-region)
  • Germany
  • U.K.
  • France
  • Spain
  • Italy
  • Scandinavia
  • Rest of Europe
• Asia Pacific (By Offering, Type, Application, End User, and Country/Sub-region)
  • China
  • Japan
  • India
  • Australia
  • Southeast Asia
  • Rest of Asia Pacific
• Latin America (By Offering, Type, Application, End User, and Country/Sub-region)
  • Brazil
  • Mexico
  • Rest of Latin America
• Middle East & Africa (By Offering, Type, Application, End User, and Country/Sub-region)
  • GCC
  • South Africa
  • Rest of Middle East & Africa

Table of Content

1. Introduction

• 1.1. Research Scope
• 1.2. Market Segmentation
• 1.3. Research Methodology
• 1.4. Definitions and Assumptions

2. Executive Summary

3. Market Dynamics

• 3.1. Market Drivers
• 3.2. Market Restraints
• 3.3. Market Opportunities
• 3.4. Market Trends
• 3.5. Market Challenges

4. Key Insights

• 4.1. Key Industry Developments (Mergers, Acquisitions, Partnerships, etc.)
• 4.2. New Product Launches, By Key Players
• 4.3. Overview: Investment Trends in Digital Biomanufacturing
• 4.4. Technological Advances in Digital Biomanufacturing

5. Global Digital Biomanufacturing Market Analysis, Insights and Forecast, 2021-2034

• 5.1. Market Analysis, Insights and Forecast - By Offering
  • 5.1.1. Software & Platforms
  • 5.1.2. Hardware & Connected Equipment
  • 5.1.3. Services
• 5.2. Market Analysis, Insights and Forecast - By Type
  • 5.2.1. Manufacturing Execution & Electronic Batch Records
  • 5.2.2. Automation & Process Control
  • 5.2.3. Process Analytical Technology & Real-time Monitoring
  • 5.2.4. Digital Twins, Modelling & Simulation
  • 5.2.5. AI, Machine Learning & Advanced Analytics
  • 5.2.6. Bioprocess Data Management & Integration
  • 5.2.7. Quality & Laboratory Informatics
  • 5.2.8. Others
• 5.3. Market Analysis, Insights and Forecast - By Application
  • 5.3.1. Process Development & Scale-up
  • 5.3.2. Commercial GMP Manufacturing Execution
  • 5.3.3. Real-time Process Monitoring & Control
  • 5.3.4. Quality Management & Batch Release
  • 5.3.5. Technology Transfer & Facility Digitalization
  • 5.3.6. Others
• 5.4. Market Analysis, Insights and Forecast - By End User
  • 5.4.1. Pharmaceuticals & Biotechnology Companies
  • 5.4.2. Academic & Research Institutes
  • 5.4.3. CMOs & CDMOs
  • 5.4.4. Others
• 5.5. Market Analysis, Insights and Forecast - Region
  • 5.5.1. North America
  • 5.5.2. Europe
  • 5.5.3. Asia Pacific
  • 5.5.4. Latin America
  • 5.5.5. Middle East & Africa

6. North America Digital Biomanufacturing Market Analysis, Insights and Forecast, 2021-2034

• 6.1. Market Analysis, Insights and Forecast - By Offering
  • 6.1.1. Software & Platforms
  • 6.1.2. Hardware & Connected Equipment
  • 6.1.3. Services
• 6.2. Market Analysis, Insights and Forecast - By Type
  • 6.2.1. Manufacturing Execution & Electronic Batch Records
  • 6.2.2. Automation & Process Control
  • 6.2.3. Process Analytical Technology & Real-time Monitoring
  • 6.2.4. Digital Twins, Modelling & Simulation
  • 6.2.5. AI, Machine Learning & Advanced Analytics
  • 6.2.6. Bioprocess Data Management & Integration
  • 6.2.7. Quality & Laboratory Informatics
  • 6.2.8. Others
• 6.3. Market Analysis, Insights and Forecast - By Application
  • 6.3.1. Process Development & Scale-up
  • 6.3.2. Commercial GMP Manufacturing Execution
  • 6.3.3. Real-time Process Monitoring & Control
  • 6.3.4. Quality Management & Batch Release
  • 6.3.5. Technology Transfer & Facility Digitalization
  • 6.3.6. Others
• 6.4. Market Analysis, Insights and Forecast - By End User
  • 6.4.1. Pharmaceuticals & Biotechnology Companies
  • 6.4.2. Academic & Research Institutes
  • 6.4.3. CMOs & CDMOs
  • 6.4.4. Others
• 6.5. Market Analysis, Insights and Forecast - By Country
  • 6.5.1. U.S.
  • 6.5.2. Canada

7. Europe Digital Biomanufacturing Market Analysis, Insights and Forecast, 2021-2034

• 7.1. Market Analysis, Insights and Forecast - By Offering
  • 7.1.1. Software & Platforms
  • 7.1.2. Hardware & Connected Equipment
  • 7.1.3. Services
• 7.2. Market Analysis, Insights and Forecast - By Type
  • 7.2.1. Manufacturing Execution & Electronic Batch Records
  • 7.2.2. Automation & Process Control
  • 7.2.3. Process Analytical Technology & Real-time Monitoring
  • 7.2.4. Digital Twins, Modelling & Simulation
  • 7.2.5. AI, Machine Learning & Advanced Analytics
  • 7.2.6. Bioprocess Data Management & Integration
  • 7.2.7. Quality & Laboratory Informatics
  • 7.2.8. Others
• 7.3. Market Analysis, Insights and Forecast - By Application
  • 7.3.1. Process Development & Scale-up
  • 7.3.2. Commercial GMP Manufacturing Execution
  • 7.3.3. Real-time Process Monitoring & Control
  • 7.3.4. Quality Management & Batch Release
  • 7.3.5. Technology Transfer & Facility Digitalization
  • 7.3.6. Others
• 7.4. Market Analysis, Insights and Forecast - By End User
  • 7.4.1. Pharmaceuticals & Biotechnology Companies
  • 7.4.2. Academic & Research Institutes
  • 7.4.3. CMOs & CDMOs
  • 7.4.4. Others
• 7.5. Market Analysis, Insights and Forecast - By Country/ Sub-Region
  • 7.5.1. U.K.
  • 7.5.2. Germany
  • 7.5.3. France
  • 7.5.4. Italy
  • 7.5.5. Spain
  • 7.5.6. Scandinavia
  • 7.5.7. Rest of Europe

8. Asia Pacific Digital Biomanufacturing Market Analysis, Insights and Forecast, 2021-2034

• 8.1. Market Analysis, Insights and Forecast - By Offering
  • 8.1.1. Software & Platforms
  • 8.1.2. Hardware & Connected Equipment
  • 8.1.3. Services
• 8.2. Market Analysis, Insights and Forecast - By Type
  • 8.2.1. Manufacturing Execution & Electronic Batch Records
  • 8.2.2. Automation & Process Control
  • 8.2.3. Process Analytical Technology & Real-time Monitoring
  • 8.2.4. Digital Twins, Modelling & Simulation
  • 8.2.5. AI, Machine Learning & Advanced Analytics
  • 8.2.6. Bioprocess Data Management & Integration
  • 8.2.7. Quality & Laboratory Informatics
  • 8.2.8. Others
• 8.3. Market Analysis, Insights and Forecast - By Application
  • 8.3.1. Process Development & Scale-up
  • 8.3.2. Commercial GMP Manufacturing Execution
  • 8.3.3. Real-time Process Monitoring & Control
  • 8.3.4. Quality Management & Batch Release
  • 8.3.5. Technology Transfer & Facility Digitalization
  • 8.3.6. Others
• 8.4. Market Analysis, Insights and Forecast - By End User
  • 8.4.1. Pharmaceuticals & Biotechnology Companies
  • 8.4.2. Academic & Research Institutes
  • 8.4.3. CMOs & CDMOs
  • 8.4.4. Others
• 8.5. Market Analysis, Insights and Forecast - By Country/ Sub-Region
  • 8.5.1. China
  • 8.5.2. Japan
  • 8.5.3. India
  • 8.5.4. Australia
  • 8.5.5. Southeast Asia
  • 8.5.6. Rest of Asia Pacific

9. Latin America Digital Biomanufacturing Market Analysis, Insights and Forecast, 2021-2034

• 9.1. Market Analysis, Insights and Forecast - By Offering
  • 9.1.1. Software & Platforms
  • 9.1.2. Hardware & Connected Equipment
  • 9.1.3. Services
• 9.2. Market Analysis, Insights and Forecast - By Type
  • 9.2.1. Manufacturing Execution & Electronic Batch Records
  • 9.2.2. Automation & Process Control
  • 9.2.3. Process Analytical Technology & Real-time Monitoring
  • 9.2.4. Digital Twins, Modelling & Simulation
  • 9.2.5. AI, Machine Learning & Advanced Analytics
  • 9.2.6. Bioprocess Data Management & Integration
  • 9.2.7. Quality & Laboratory Informatics
  • 9.2.8. Others
• 9.3. Market Analysis, Insights and Forecast - By Application
  • 9.3.1. Process Development & Scale-up
  • 9.3.2. Commercial GMP Manufacturing Execution
  • 9.3.3. Real-time Process Monitoring & Control
  • 9.3.4. Quality Management & Batch Release
  • 9.3.5. Technology Transfer & Facility Digitalization
  • 9.3.6. Others
• 9.4. Market Analysis, Insights and Forecast - By End User
  • 9.4.1. Pharmaceuticals & Biotechnology Companies
  • 9.4.2. Academic & Research Institutes
  • 9.4.3. CMOs & CDMOs
  • 9.4.4. Others
• 9.5. Market Analysis, Insights and Forecast - By Country/ Sub-Region
  • 9.5.1. Brazil
  • 9.5.2. Mexico
  • 9.5.3. Rest of Latin America

10. Middle East & Africa Digital Biomanufacturing Market Analysis, Insights and Forecast, 2021-2034

• 10.1. Market Analysis, Insights and Forecast - By Offering
  • 10.1.1. Software & Platforms
  • 10.1.2. Hardware & Connected Equipment
  • 10.1.3. Services
• 10.2. Market Analysis, Insights and Forecast - By Type
  • 10.2.1. Manufacturing Execution & Electronic Batch Records
  • 10.2.2. Automation & Process Control
  • 10.2.3. Process Analytical Technology & Real-time Monitoring
  • 10.2.4. Digital Twins, Modelling & Simulation
  • 10.2.5. AI, Machine Learning & Advanced Analytics
  • 10.2.6. Bioprocess Data Management & Integration
  • 10.2.7. Quality & Laboratory Informatics
  • 10.2.8. Others
• 10.3. Market Analysis, Insights and Forecast - By Application
  • 10.3.1. Process Development & Scale-up
  • 10.3.2. Commercial GMP Manufacturing Execution
  • 10.3.3. Real-time Process Monitoring & Control
  • 10.3.4. Quality Management & Batch Release
  • 10.3.5. Technology Transfer & Facility Digitalization
  • 10.3.6. Others
• 10.4. Market Analysis, Insights and Forecast - By End User
  • 10.4.1. Pharmaceuticals & Biotechnology Companies
  • 10.4.2. Academic & Research Institutes
  • 10.4.3. CMOs & CDMOs
  • 10.4.4. Others
• 10.5. Market Analysis, Insights and Forecast - By Country/ Sub-Region
  • 10.5.1. GCC
  • 10.5.2. South Africa
  • 10.5.3. Rest of Middle East & Africa

11. Competitive Analysis

• 11.1. Global Market Share Analysis (2025)
• 11.2. Company Profiles
  • 11.2.1. Siemens
  • 11.2.2. Sartorius AG
  • 11.2.3. Danaher Corporation (Cytiva)
  • 11.2.4. Emerson Electric Co.
  • 11.2.5. Korber AG.
  • 11.2.6. Aspen Technology
  • 11.2.7. Benchling
  • 11.2.8. TetraScience, Inc.
  • 11.2.9. Schneider Electric
  • 11.2.10. Other Prominent Players